The reagent kit is designed for qualitative detection of Varicella–Zoster virus genomic DNA specific region.
The reagent kit is designed for determination of BRAF and KRAS genes mutation status and is used for patients examination diagnosed with tumor diseases, mainly lung cancer, in order to determine an effective strategy for targeted therapy, predict or monitor the response to cancer therapy and the risk of recurrence or metastasis, regardless of the disease stage in all population gropus.
The reagent kit in lyophilized form is designed for qualitative detection of viral respiratory infection caused by the SARS-CoV-2 coronavirus. RNA isolation from clinical material is not required.
The reagent kit is designed for qualitative Helicobacter pylori DNA detection by real-time PCR with hybridization fluorescence detection in a DNA sample isolated from clinical material in patients with suspected helicobacteriosis and associated gastrointestinal diseases.
The reagent kit HPV-test is designed for qualitative and quantitative human papillomavirus HPV DNA detection and differentiation of low carcinogenic risk 6, 11, 44 genotypes and high carcinogenic risk 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 68, 56, 58, 59, 66, 53, 73, 82 types.
The kit is designed for detection of the hepatitis C virus and its genotypes (1a, 1b, 2, 3) .